vs
阿普塔集团（ATR）与Broadridge Financial Solutions（BR）财务数据对比。点击上方公司名可切换其他公司
Broadridge Financial Solutions的季度营收约是阿普塔集团的1.8倍（$1.7B vs $962.7M），Broadridge Financial Solutions净利率更高（16.6% vs 7.7%，领先8.9%），阿普塔集团同比增速更快（13.5% vs -5.4%），过去两年Broadridge Financial Solutions的营收复合增速更高（10.4% vs 2.6%）
阿普塔集团（AptarGroup, Inc.）是总部位于美国的全球性制造企业，主营消费品分配包装产品及药物给药装置的研发与生产，目前在全球18个国家设有生产运营基地，服务医药、快消等多领域客户。
Broadridge Financial Solutions是2007年从自动数据处理公司（ADP）分拆成立的上市企业服务及金融科技企业，总部位于纽约莱克萨克塞斯，为金融行业客户提供股东委托书、年报等金融单证服务，以及线上年会等股东沟通解决方案。
ATR vs BR — 直观对比
营收规模更大
BR
是对方的1.8倍
$962.7M
营收增速更快
ATR
高出18.9%
-5.4%
净利率更高
BR
高出8.9%
7.7%
两年增速更快
BR
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $962.7M | $1.7B |
| 净利润 | $74.3M | $284.6M |
| 毛利率 | — | 27.6% |
| 营业利润率 | 11.0% | 12.0% |
| 净利率 | 7.7% | 16.6% |
| 营收同比 | 13.5% | -5.4% |
| 净利润同比 | -26.4% | 17.1% |
| 每股收益（稀释后） | $1.13 | $2.42 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRBR
| Q4 25 | $962.7M | $1.7B | ||
| Q3 25 | $961.1M | — | ||
| Q2 25 | $966.0M | $2.1B | ||
| Q1 25 | $887.3M | $1.8B | ||
| Q4 24 | $848.1M | $1.6B | ||
| Q3 24 | $909.3M | $1.4B | ||
| Q2 24 | $910.1M | $1.9B | ||
| Q1 24 | $915.4M | $1.7B |
净利润ATRBR
| Q4 25 | $74.3M | $284.6M | ||
| Q3 25 | $127.9M | — | ||
| Q2 25 | $111.7M | $374.2M | ||
| Q1 25 | $78.8M | $243.1M | ||
| Q4 24 | $100.9M | $142.4M | ||
| Q3 24 | $100.0M | $79.8M | ||
| Q2 24 | $90.5M | $323.2M | ||
| Q1 24 | $83.1M | $213.7M |
毛利率ATRBR
| Q4 25 | — | 27.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 37.3% | ||
| Q1 25 | — | 31.8% | ||
| Q4 24 | — | 27.9% | ||
| Q3 24 | — | 24.5% | ||
| Q2 24 | — | 35.5% | ||
| Q1 24 | — | 31.2% |
营业利润率ATRBR
| Q4 25 | 11.0% | 12.0% | ||
| Q3 25 | 14.2% | — | ||
| Q2 25 | 14.9% | 24.1% | ||
| Q1 25 | 12.8% | 19.0% | ||
| Q4 24 | 14.2% | 13.3% | ||
| Q3 24 | 15.2% | 9.4% | ||
| Q2 24 | 13.8% | 22.7% | ||
| Q1 24 | 12.2% | 17.5% |
净利率ATRBR
| Q4 25 | 7.7% | 16.6% | ||
| Q3 25 | 13.3% | — | ||
| Q2 25 | 11.6% | 18.1% | ||
| Q1 25 | 8.9% | 13.4% | ||
| Q4 24 | 11.9% | 9.0% | ||
| Q3 24 | 11.0% | 5.6% | ||
| Q2 24 | 9.9% | 16.6% | ||
| Q1 24 | 9.1% | 12.4% |
每股收益（稀释后）ATRBR
| Q4 25 | $1.13 | $2.42 | ||
| Q3 25 | $1.92 | — | ||
| Q2 25 | $1.67 | $3.17 | ||
| Q1 25 | $1.17 | $2.05 | ||
| Q4 24 | $1.48 | $1.20 | ||
| Q3 24 | $1.48 | $0.68 | ||
| Q2 24 | $1.34 | $2.72 | ||
| Q1 24 | $1.23 | $1.79 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $409.5M | $371.5M |
| 总债务越低越好 | $1.1B | $3.2B |
| 股东权益账面价值 | $2.7B | $2.9B |
| 总资产 | $5.3B | $8.6B |
| 负债/权益比越低杠杆越低 | 0.43× | 1.10× |
8季度趋势，按日历期对齐
现金及短期投资ATRBR
| Q4 25 | $409.5M | $371.5M | ||
| Q3 25 | $264.8M | — | ||
| Q2 25 | $169.8M | $562.2M | ||
| Q1 25 | $136.8M | $317.9M | ||
| Q4 24 | $226.2M | $290.6M | ||
| Q3 24 | $327.9M | $293.5M | ||
| Q2 24 | $223.9M | $305.2M | ||
| Q1 24 | $201.1M | $236.4M |
总债务ATRBR
| Q4 25 | $1.1B | $3.2B | ||
| Q3 25 | $546.0M | — | ||
| Q2 25 | $535.1M | $3.3B | ||
| Q1 25 | $561.2M | $3.4B | ||
| Q4 24 | $688.1M | $3.7B | ||
| Q3 24 | $822.7M | $3.6B | ||
| Q2 24 | $681.5M | $3.4B | ||
| Q1 24 | $680.4M | $3.5B |
股东权益ATRBR
| Q4 25 | $2.7B | $2.9B | ||
| Q3 25 | $2.8B | — | ||
| Q2 25 | $2.7B | $2.7B | ||
| Q1 25 | $2.5B | $2.4B | ||
| Q4 24 | $2.5B | $2.2B | ||
| Q3 24 | $2.5B | $2.2B | ||
| Q2 24 | $2.4B | $2.2B | ||
| Q1 24 | $2.3B | $2.3B |
总资产ATRBR
| Q4 25 | $5.3B | $8.6B | ||
| Q3 25 | $5.1B | — | ||
| Q2 25 | $4.9B | $8.5B | ||
| Q1 25 | $4.5B | $8.3B | ||
| Q4 24 | $4.4B | $8.2B | ||
| Q3 24 | $4.6B | $8.0B | ||
| Q2 24 | $4.5B | $8.2B | ||
| Q1 24 | $4.4B | $8.2B |
负债/权益比ATRBR
| Q4 25 | 0.43× | 1.10× | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | 1.22× | ||
| Q1 25 | 0.22× | 1.44× | ||
| Q4 24 | 0.28× | 1.64× | ||
| Q3 24 | 0.32× | 1.63× | ||
| Q2 24 | 0.28× | 1.55× | ||
| Q1 24 | 0.29× | 1.55× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.7M | — |
| 自由现金流经营现金流 - 资本支出 | $96.9M | — |
| 自由现金流率自由现金流/营收 | 10.1% | — |
| 资本支出强度资本支出/营收 | 9.0% | — |
| 现金转化率经营现金流/净利润 | 2.47× | — |
| 过去12个月自由现金流最近4个季度 | $299.6M | — |
8季度趋势，按日历期对齐
经营现金流ATRBR
| Q4 25 | $183.7M | — | ||
| Q3 25 | $177.6M | — | ||
| Q2 25 | $126.0M | $699.7M | ||
| Q1 25 | $82.7M | $360.4M | ||
| Q4 24 | $178.2M | $236.7M | ||
| Q3 24 | $229.3M | $-125.5M | ||
| Q2 24 | $143.6M | $721.0M | ||
| Q1 24 | $92.3M | $207.4M |
自由现金流ATRBR
| Q4 25 | $96.9M | — | ||
| Q3 25 | $114.3M | — | ||
| Q2 25 | $62.5M | $684.1M | ||
| Q1 25 | $25.9M | $348.9M | ||
| Q4 24 | $112.2M | $227.9M | ||
| Q3 24 | $162.7M | $-133.4M | ||
| Q2 24 | $75.4M | $703.2M | ||
| Q1 24 | $16.7M | $184.6M |
自由现金流率ATRBR
| Q4 25 | 10.1% | — | ||
| Q3 25 | 11.9% | — | ||
| Q2 25 | 6.5% | 33.1% | ||
| Q1 25 | 2.9% | 19.3% | ||
| Q4 24 | 13.2% | 14.3% | ||
| Q3 24 | 17.9% | -9.4% | ||
| Q2 24 | 8.3% | 36.2% | ||
| Q1 24 | 1.8% | 10.7% |
资本支出强度ATRBR
| Q4 25 | 9.0% | — | ||
| Q3 25 | 6.6% | — | ||
| Q2 25 | 6.6% | 0.8% | ||
| Q1 25 | 6.4% | 0.6% | ||
| Q4 24 | 7.8% | 0.6% | ||
| Q3 24 | 7.3% | 0.6% | ||
| Q2 24 | 7.5% | 0.9% | ||
| Q1 24 | 8.3% | 1.3% |
现金转化率ATRBR
| Q4 25 | 2.47× | — | ||
| Q3 25 | 1.39× | — | ||
| Q2 25 | 1.13× | 1.87× | ||
| Q1 25 | 1.05× | 1.48× | ||
| Q4 24 | 1.77× | 1.66× | ||
| Q3 24 | 2.29× | -1.57× | ||
| Q2 24 | 1.59× | 2.23× | ||
| Q1 24 | 1.11× | 0.97× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
BR
| Recurring Fee Revenue Investor Communication Solutions | $589.5M | 34% |
| Recurring Fee Revenue Capital Markets | $300.9M | 18% |
| Recurring Fee Revenue Regulatory | $248.7M | 15% |
| Recurring Fee Revenue Customer Communications | $189.2M | 11% |
| Recurring Fee Revenue Wealth And Investment Management | $179.7M | 10% |
| Recurring Fee Revenue Data Driven Fund Solutions | $112.7M | 7% |
| Event Driven Revenue Mutual Funds | $51.4M | 3% |
| Event Driven Revenue Equity And Other | $39.2M | 2% |
| Global Technology And Operations | $7.5M | 0% |
